Replies to post #203041 on Biotech Values

[biomaven0]

It was noted by JQ on twitter yesterday that the proposed regimen for this patient excludes Abraxane.


Quoting the clinical trials listing "it is felt that she cannot tolerate more aggressive chemotherapy."

So not too significant for FGEN one way or another.